Oct26Thu

For Immediate Release

  

FOR IMMEDIATE RELEASE

Irish American Business Chamber and ICON Clinical Research partner to present Life Sciences Forum

Philadelphia, PA, October 26, 2017 – The Irish American Business Chamber & Network has announced that it will partner with Ambassador Club member, ICON Clinical Research, to present their third annual Life Sciences Forum on November 16th at ICON’s largest US office in North Wales, PA. The forum is proudly sponsored by Aer Lingus.

Key note speaker, Dr. Garret FitzGerald, Director, Institute for Translational Medicine & Therapeutics at the University of Pennsylvania and winner of the prestigious Science Foundation Ireland St. Patrick’s Day Medal, will open the forum. The dynamic panel will feature Dr. Andrea Perrone, MD, Associate Vice President, Clinical Imaging Translational Medicine at Merck & Co and Mr. Joseph Sirianni, Senior Director Global Engineering Services, Zoetis, and will be moderated by Paul McCracken Ph.D., Vice President, Head of Medical Imaging, ICON plc.

Read More

Oct24Tue

PA Trade Mission in Co. Mayo

#IABCN members, Joe Burke (center) and Michael O’Rourke (far right) representing PA Trade Mission, meeting with Mayo County Council Economic Development Group this week.

PA Trade Mission visit to the McHale headquarters, just outside Ballinrobe, County Mayo.

#IABCN member, Joe Burke (2nd to left) with 2 Mayo County Council Economic Development Reps and (3rd from left) Paul McHale, Sales Manager; (center) Gene Barr, President & CEO of PA Chamber of Business and Industry; (2nd from right) Padraic McHale, Co-Owner and Founder.

McHale employs 250+, with 25% of their workforce is dedicated to R&D.

Oct24Tue

Member News from Almac Group

Almac Group Introduces Accountability and Reconciliation Tracking Fully Configurable Extension of IXRS®3 Provides End-to-End Traceability of IMP

Souderton, PA – 24 October 2017 – Almac Clinical Technologies, a global leader in technology-enabled solutions for managing clinical trial patient and supplies data, has extended the functionality of its industry-leading IXRS® 3 IRT platform to include Accountability and Reconciliation Tracking (ART™).

ART captures all accountability data relating to the assignment, dispensation, and return of investigational medicinal products (IMP) throughout the course of a clinical trial. The toolkit provides total control over—and visibility into—the entire chain of custody down to the individual IMP unit level. This improves trial oversight, reduces dispensation errors, and strengthens patient safety.

Read More

Oct24Tue

Member News from Aramark

Aramark Launches National Park Vacation Planning Website

Aramark (NYSE: ARMK), the award-winning food and hospitality partner for national and state parks and other leading leisure and cultural attractions, announced the launch of its new travel website, The Nation’s Vacation (www.TheNationsVacation.com), dedicated to helping travelers find the national park destination that best suits their vacation desires.

“With the introduction of our new Nation’s Vacation website, we’ve developed a convenient, one-stop-booking tool that helps park enthusiasts and first-time travelers alike discover the many activities and experiences available at each park, simplifies their decision making and planning process, and allows for easy online reservations”
Read More

Oct23Mon

Member News from Almac Group

Queen’s University Belfast in Collaboration with Almac Group Lead Largest Study of its Kind to Transform Prostate Cancer Treatment

Craigavon, N.I., UK, 23 October 2017 – Queen’s University Belfast have led the world’s largest research study using a diagnostic test developed by Almac Diagnostics, to better understand the biology of prostate cancer tumours, which could lead to a transformation in how prostate cancer is diagnosed and treated.

Whether a prostate cancer patient has a slow-growing or aggressive tumour will affect the type of treatment required. It is only through understanding the type and genetics of the particular cancer tumour that clinicians will be able to put an effective treatment plan in place.

Read More